Ausgabe 4/2017
Inhalt (6 Artikel)
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Masao Omata, Ann-Lii Cheng, Norihiro Kokudo, Masatoshi Kudo, Jeong Min Lee, Jidong Jia, Ryosuke Tateishi, Kwang-Hyub Han, Yoghesh K. Chawla, Shuichiro Shiina, Wasim Jafri, Diana Alcantara Payawal, Takamasa Ohki, Sadahisa Ogasawara, Pei-Jer Chen, Cosmas Rinaldi A. Lesmana, Laurentius A. Lesmana, Rino A. Gani, Shuntaro Obi, A. Kadir Dokmeci, Shiv Kumar Sarin
Extracorporeal devices for treatment of refractory pruritus in cholestatic liver disease
Roger Williams
Current progress in host innate and adaptive immunity against hepatitis C virus infection
Jijing Shi, Yuanyuan Li, Wenxian Chang, Xuexiu Zhang, Fu-Sheng Wang
Charcoal hemoperfusion in the treatment of medically refractory pruritus in cholestatic liver disease
Wonngarm Kittanamongkolchai, Ziad M. El-Zoghby, J. Eileen Hay, Russell H. Wiesner, Patrick S. Kamath, Nicholas F. LaRusso, Kymberly D. Watt, Carl H. Cramer, Nelson Leung
Safety, pharmacokinetics and pharmacogenetics of a single ascending dose of pradefovir, a novel liver-targeting, anti-hepatitis B virus drug, in healthy Chinese subjects
Yanhua Ding, Hong Zhang, Xiaojiao Li, Cuiyun Li, Guiling Chen, Hong Chen, Min Wu, Junqi Niu
Noninvasive serum models to predict significant liver related events in chronic hepatitis C
Ragesh Babu Thandassery, Saad Al Kaabi, Madiha E. Soofi, Benjamin Tharian, Rajvir Singh